Recent Trends in Dry Eye Disease Treatment in Asia

Author:

Kawahara AtsushiORCID

Abstract

Purpose of review. Summarize recent trends in the treatment of dry eye disease (DED) in Asia. Recent findings. In recent years, effective new generation eye drops, such as dicuafosol ophthalmic solution and rebamipide ophthalmic solution, which are mucin secretion stimulants, and cyclosporine ophthalmic solution, an immunosuppressive agent, have been approved in various countries for the treatment of DED. Additional newer adjunctive therapies such as laser acupuncture as an adjunctive therapy when eye drops do not provide satisfactory results, new generation intense pulsed light therapy for meibomian gland dysfunction-related DED, and human umbilical cord serum eye drops for severe DED are also of interest. These adjunctive therapies target the suppression of inflammation primarily. Summary. New generation eye drops have made it possible to control mild DED. For patients with moderate to severe disease, the addition of eye drops and adjunctive treatment is recommended. Because DED with an unstable tear film is common in Asia, treatment of DED in Asia might first include mucin secretion-promoting eye drops, with anti-inflammatory treatment preferred if additional treatment is needed. In addition, further research is needed to improve treatment continuity because DED is a chronic disease requiring continuous treatment.

Publisher

Qeios Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3